These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31255441)

  • 21. Pelvic exenteration for recurrent and extensive primary colorectal adenocarcinoma.
    Yeung RS; Moffat FL; Falk RE
    Cancer; 1993 Sep; 72(6):1853-8. PubMed ID: 7689919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pelvic exenteration, a surgical treatment option for locally advanced, primary and recurrent neoplasia.
    Muşină AM; Huţanu I; Grigore M; Scripcariu IS; Filip B; Aniţei MG; Scripcariu DV; Gavrilescu MM; Radu I; Ioanid N; Pantazescu AN; Hogea M; Panuţa A; Buna-Arvinte M; Moraru GV; Scripcariu V
    Rom J Morphol Embryol; 2019; 60(4):1175-1182. PubMed ID: 32239092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of Pelvic Exenteration with en Bloc Partial or Complete Pubic Bone Excision for Locally Advanced Primary or Recurrent Pelvic Cancer.
    Austin KK; Herd AJ; Solomon MJ; Ly K; Lee PJ
    Dis Colon Rectum; 2016 Sep; 59(9):831-5. PubMed ID: 27505111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pelvic Exenteration for Locally Advanced and Relapsed Pelvic Malignancies - An Analysis of 100 Cases.
    Bacalbasa N; Balescu I; Vilcu M; Neacsu A; Dima S; Croitoru A; Brezean I
    In Vivo; 2019; 33(6):2205-2210. PubMed ID: 31662557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laparoscopic pelvic exenteration for advanced pelvic cancers: a review of 16 cases.
    Puntambekar S; Kudchadkar RJ; Gurjar AM; Sathe RM; Chaudhari YC; Agarwal GA; Rayate NV
    Gynecol Oncol; 2006 Sep; 102(3):513-6. PubMed ID: 16510172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short- and long-term outcomes following pelvic exenteration for gynae-oncological and colorectal cancers: A 9 year consecutive single-centre cohort study.
    Katory M; McLean R; Paez E; Kucukmetin A; Naik R
    Int J Surg; 2017 Jul; 43():38-45. PubMed ID: 28529192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A single-institution approach to total pelvic exenteration.
    Chokshi RJ; Fowler J; Cohn D; Bahnson R; Lumbley J; Martin EW
    Am Surg; 2011 Dec; 77(12):1629-39. PubMed ID: 22273221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Palliative pelvic radiotherapy of symptomatic incurable rectal cancer - a systematic review.
    Cameron MG; Kersten C; Vistad I; Fosså S; Guren MG
    Acta Oncol; 2014 Feb; 53(2):164-73. PubMed ID: 24195692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Total pelvic exenteration: effective palliation of perineal pain in patients with locally recurrent prostate cancer.
    Kamat AM; Huang SF; Bermejo CE; Rosser CJ; Pettaway CA; Pisters PW; Guitreau D; Pisters LL
    J Urol; 2003 Nov; 170(5):1868-71. PubMed ID: 14532795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pelvic exenteration for advanced pelvic malignancy.
    Crowe PJ; Temple WJ; Lopez MJ; Ketcham AS
    Semin Surg Oncol; 1999; 17(3):152-60. PubMed ID: 10504662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of pelvic exenteration for locally advanced primary rectal cancer: Overall survival and quality of life.
    Quyn AJ; Austin KK; Young JM; Badgery-Parker T; Masya LM; Roberts R; Solomon MJ
    Eur J Surg Oncol; 2016 Jun; 42(6):823-8. PubMed ID: 26947962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exenterative pelvic surgery--eleven year experience of the Swansea Pelvic Oncology Group.
    Nguyen DQ; McGregor AD; Freites O; Carr ND; Beynon J; El-Sharkawi AM; Lucas MG
    Eur J Surg Oncol; 2005 Dec; 31(10):1180-4. PubMed ID: 16126362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcomes of pelvic exenteration for locally advanced primary or recurrent non-colorectal pelvic malignancies.
    Ueda T; Koyama F; Nakagawa T; Nakamura S; Nishigori N; Inoue T; Kawasaki K; Obara S; Nakamoto T; Fujii H; Nakajima Y
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2433-6. PubMed ID: 24394136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pelvic exenteration in patients with locally advanced, symptomatic castration-resistant prostate cancer].
    Kanzelmeyer S; Bludau M; Pfister DJKP; Heidenreich A
    Urologe A; 2022 Feb; 61(2):167-172. PubMed ID: 34424358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overview of the Role of Imaging in Pelvic Exenteration.
    Sagebiel TL; Viswanathan C; Patnana M; Devine CE; Frumovitz M; Bhosale PR
    Radiographics; 2015; 35(4):1286-94. PubMed ID: 26172363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Total pelvic exenteration with preservation of fecal continence.
    Brodsky JT; Sloane BB; Khanna OP
    J Surg Oncol; 1993 Aug; 53(4):261-4. PubMed ID: 8341059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utilising quality of life outcome trajectories to aid patient decision making in pelvic exenteration.
    Harji DP; Williams A; McKigney N; Boissieras L; Denost Q; Fearnhead NS; Jenkins JT; Griffiths B
    Eur J Surg Oncol; 2022 Nov; 48(11):2238-2249. PubMed ID: 36030134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Price We Pay for Radical Curative Pelvic Exenterations: Prevalence and Management of Pain.
    Lim JS; Koh CE; Liu H; Solomon MJ; Johnstone CSH
    Dis Colon Rectum; 2018 Mar; 61(3):314-319. PubMed ID: 29420427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opportunities and Limitations of Pelvic Exenteration Surgery.
    Lampe B; Luengas-Würzinger V; Weitz J; Roth S; Rawert F; Schuler E; Classen-von Spee S; Fix N; Baransi S; Dizdar A; Mallmann P; Schaser KD; Bogner A
    Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Total pelvic exenteration. Apropos of 49 cases].
    Ranieri J; Tilliard JP
    Chirurgie; 1989; 115(1):48-56; discussion 57. PubMed ID: 2676419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.